DrugDashboards

Dextrose

Dextrose Monohydrate · DEXTROSE MONOHYDRATE 50 mg/mL · Injection, Solution · Intravenous · Fresenius Kabi USA, LLC

NDC 63323-0624-75 · 20 BAG in 1 CASE / 500 mL in 1 BAG · ANDA · View full market →

The short version

14 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$1.65per billing unit (500 ML)HCPCS J7060 · Jul 1, 2026
  • Federal contracts pay (FSS)$42.21per package of 20X500MLFresenius Kabi, LLC · May 15, 2025

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 65219-0464-50) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$0.0206per unit
middle half $0.0140–$0.0427 · 5,477 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.0206
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
100%of plans cover it
tier 2 · prior auth 1% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 6 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$64.00
Reported to Texas DSHS · 2024 annual filing · Fresenius Kabi Usa

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 500 ML
$1.649
HCPCS J7060 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2024)

$2
14 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA207449
TE code
AP
Approval date
Oct 21, 2016
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0074-30)Jul 20, 2026
    month 2 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — DEXTROSE 70% IN PLASTIC CONTAINER, Injection, 70 g/100 mL (NDC 0990-7120-07)Oct 11, 2024
    month 23 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose Monohydrate 70%, Injection, 70 g/100 mL (NDC 0338-0719-06)Oct 11, 2024
    Other
    month 23 of a typical 20 for injectable shortages · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-02)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-03)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 10 g/100 mL (NDC 0990-7930-09)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-02)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-03)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 g/1000 mL (NDC 0338-0023-04)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-74)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-75)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 10% In Plastic Container, Injection, 100 mg/1 mL (NDC 63323-824-76)Mar 1, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0062-30)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0066-20)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0070-10)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0338-0078-20)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-02)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-03)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-09)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months
  • In shortage now — Dextrose 5% In Plastic Container, Injection, 5 g/100 mL (NDC 0990-7922-55)Feb 14, 2022
    month 55 — 3× the typical 20-month injectable shortage · model puts 26% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Dextrose Monohydrate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 5 g/100mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 2.5 g/50mLJul 15, 2026Sep 3, 2026
Fresenius Kabi Usa, LlcDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 3, 2026
ICU Medical, Inc.DEXTROSE MONOHYDRATE 5 g/100mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 3, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 50 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 100 g/1000mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationDEXTROSE MONOHYDRATE 70 g/100mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanyDEXTROSE MONOHYDRATE 100 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson and CompanyDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
Becton Dickinson And CompanyDEXTROSE MONOHYDRATE 2500 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 12500 mg/250mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 5000 mg/100mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 2500 mg/50mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 25000 mg/500mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCDEXTROSE MONOHYDRATE 100 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
ICU Medical Inc.DEXTROSE MONOHYDRATE 70 g/100mLJul 15, 2026Sep 2, 2026
ICU Medical, Inc.DEXTROSE MONOHYDRATE 10 g/100mLJul 15, 2026Sep 2, 2026
International Medication Systems, LimitedDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
Medical Purchasing Solutions, LLCDEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDEXTROSE MONOHYDRATE 50 mg/mLJul 15, 2026Sep 2, 2026
ProPharma DistributionDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXTROSE MONOHYDRATE 250 mg/mLJul 15, 2026Sep 2, 2026
Remedyrepack Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Sep 2, 2026
HF Acquisition Co LLC, DBA HealthFirstDEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Aug 29, 2026
Hospira, Inc.DEXTROSE MONOHYDRATE 25 g/50mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Dextrose — NDC 63323-0624-75," retrieved September 3, 2026, https://drugdashboards.com/drug/63323062475.

Free to cite with attribution — see how the data is put together.